PMV Pharmaceuticals, Inc.
PMVP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $77,884 | $148,843 | $396,675 | $1,042,680 |
| - Cash | $40,876 | $37,706 | $108,297 | $172,467 |
| + Debt | $1,190 | $13,286 | $13,976 | $11,193 |
| Enterprise Value | $38,198 | $124,423 | $302,354 | $881,406 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1,144 | -$1,257 | -$650 | -$1,281 |
| % Margin | – | – | – | – |
| EBITDA | -$73,665 | -$67,701 | -$72,676 | -$56,542 |
| % Margin | – | – | – | – |
| Net Income | -$58,709 | -$68,960 | -$73,317 | -$57,846 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.138 | -1.44 | -1.61 | -1.28 |
| % Growth | 21% | 10.6% | -25.8% | – |
| Operating Cash Flow | -$51,282 | -$55,657 | -$63,760 | -$46,571 |
| Capital Expenditures | -$655 | -$962 | -$7,984 | -$1,349 |
| Free Cash Flow | -$51,937 | -$56,619 | -$71,744 | -$47,920 |